This report contains market size and forecasts of Non-opioid Pain Patch in global, including the following market information:
Global Non-opioid Pain Patch Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Non-opioid Pain Patch Market Sales, 2016-2021, 2022-2027, (M Units)
Global top five Non-opioid Pain Patch companies in 2020 (%)
The global Non-opioid Pain Patch market was valued at 649.7 million in 2020 and is projected to reach US$ 716.8 million by 2027, at a CAGR of 2.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-opioid Pain Patch manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-opioid Pain Patch Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units)
Global Non-opioid Pain Patch Market Segment Percentages, By Type, 2020 (%)
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Fentanyl Patches
Others
Global Non-opioid Pain Patch Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units)
Global Non-opioid Pain Patch Market Segment Percentages, By Application, 2020 (%)
OTC
Rx
Global Non-opioid Pain Patch Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Units)
Global Non-opioid Pain Patch Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-opioid Pain Patch revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Non-opioid Pain Patch revenues share in global market, 2020 (%)
Key companies Non-opioid Pain Patch sales in global market, 2016-2021 (Estimated), (M Units)
Key companies Non-opioid Pain Patch sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Non-opioid Pain Patch Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-opioid Pain Patch Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-opioid Pain Patch Overall Market Size
2.1 Global Non-opioid Pain Patch Market Size: 2021 VS 2027
2.2 Global Non-opioid Pain Patch Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Non-opioid Pain Patch Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Non-opioid Pain Patch Players in Global Market
3.2 Top Global Non-opioid Pain Patch Companies Ranked by Revenue
3.3 Global Non-opioid Pain Patch Revenue by Companies
3.4 Global Non-opioid Pain Patch Sales by Companies
3.5 Global Non-opioid Pain Patch Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Non-opioid Pain Patch Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Non-opioid Pain Patch Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-opioid Pain Patch Players in Global Market
3.8.1 List of Global Tier 1 Non-opioid Pain Patch Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-opioid Pain Patch Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-opioid Pain Patch Market Size Markets, 2021 & 2027
4.1.2 Lidocaine Patches
4.1.3 Diclofenac Patches
4.1.4 Indomethacin Patches
4.1.5 Counter-Irritant Patches
4.1.6 Fentanyl Patches
4.1.7 Others
4.2 By Type - Global Non-opioid Pain Patch Revenue & Forecasts
4.2.1 By Type - Global Non-opioid Pain Patch Revenue, 2016-2021
4.2.2 By Type - Global Non-opioid Pain Patch Revenue, 2022-2027
4.2.3 By Type - Global Non-opioid Pain Patch Revenue Market Share, 2016-2027
4.3 By Type - Global Non-opioid Pain Patch Sales & Forecasts
4.3.1 By Type - Global Non-opioid Pain Patch Sales, 2016-2021
4.3.2 By Type - Global Non-opioid Pain Patch Sales, 2022-2027
4.3.3 By Type - Global Non-opioid Pain Patch Sales Market Share, 2016-2027
4.4 By Type - Global Non-opioid Pain Patch Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-opioid Pain Patch Market Size, 2021 & 2027
5.1.2 OTC
5.1.3 Rx
5.2 By Application - Global Non-opioid Pain Patch Revenue & Forecasts
5.2.1 By Application - Global Non-opioid Pain Patch Revenue, 2016-2021
5.2.2 By Application - Global Non-opioid Pain Patch Revenue, 2022-2027
5.2.3 By Application - Global Non-opioid Pain Patch Revenue Market Share, 2016-2027
5.3 By Application - Global Non-opioid Pain Patch Sales & Forecasts
5.3.1 By Application - Global Non-opioid Pain Patch Sales, 2016-2021
5.3.2 By Application - Global Non-opioid Pain Patch Sales, 2022-2027
5.3.3 By Application - Global Non-opioid Pain Patch Sales Market Share, 2016-2027
5.4 By Application - Global Non-opioid Pain Patch Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Non-opioid Pain Patch Market Size, 2021 & 2027
6.2 By Region - Global Non-opioid Pain Patch Revenue & Forecasts
6.2.1 By Region - Global Non-opioid Pain Patch Revenue, 2016-2021
6.2.2 By Region - Global Non-opioid Pain Patch Revenue, 2022-2027
6.2.3 By Region - Global Non-opioid Pain Patch Revenue Market Share, 2016-2027
6.3 By Region - Global Non-opioid Pain Patch Sales & Forecasts
6.3.1 By Region - Global Non-opioid Pain Patch Sales, 2016-2021
6.3.2 By Region - Global Non-opioid Pain Patch Sales, 2022-2027
6.3.3 By Region - Global Non-opioid Pain Patch Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Non-opioid Pain Patch Revenue, 2016-2027
6.4.2 By Country - North America Non-opioid Pain Patch Sales, 2016-2027
6.4.3 US Non-opioid Pain Patch Market Size, 2016-2027
6.4.4 Canada Non-opioid Pain Patch Market Size, 2016-2027
6.4.5 Mexico Non-opioid Pain Patch Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Non-opioid Pain Patch Revenue, 2016-2027
6.5.2 By Country - Europe Non-opioid Pain Patch Sales, 2016-2027
6.5.3 Germany Non-opioid Pain Patch Market Size, 2016-2027
6.5.4 France Non-opioid Pain Patch Market Size, 2016-2027
6.5.5 U.K. Non-opioid Pain Patch Market Size, 2016-2027
6.5.6 Italy Non-opioid Pain Patch Market Size, 2016-2027
6.5.7 Russia Non-opioid Pain Patch Market Size, 2016-2027
6.5.8 Nordic Countries Non-opioid Pain Patch Market Size, 2016-2027
6.5.9 Benelux Non-opioid Pain Patch Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Non-opioid Pain Patch Revenue, 2016-2027
6.6.2 By Region - Asia Non-opioid Pain Patch Sales, 2016-2027
6.6.3 China Non-opioid Pain Patch Market Size, 2016-2027
6.6.4 Japan Non-opioid Pain Patch Market Size, 2016-2027
6.6.5 South Korea Non-opioid Pain Patch Market Size, 2016-2027
6.6.6 Southeast Asia Non-opioid Pain Patch Market Size, 2016-2027
6.6.7 India Non-opioid Pain Patch Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Non-opioid Pain Patch Revenue, 2016-2027
6.7.2 By Country - South America Non-opioid Pain Patch Sales, 2016-2027
6.7.3 Brazil Non-opioid Pain Patch Market Size, 2016-2027
6.7.4 Argentina Non-opioid Pain Patch Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-opioid Pain Patch Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Non-opioid Pain Patch Sales, 2016-2027
6.8.3 Turkey Non-opioid Pain Patch Market Size, 2016-2027
6.8.4 Israel Non-opioid Pain Patch Market Size, 2016-2027
6.8.5 Saudi Arabia Non-opioid Pain Patch Market Size, 2016-2027
6.8.6 UAE Non-opioid Pain Patch Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Hisamitsu
7.1.1 Hisamitsu Corporate Summary
7.1.2 Hisamitsu Business Overview
7.1.3 Hisamitsu Non-opioid Pain Patch Major Product Offerings
7.1.4 Hisamitsu Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.1.5 Hisamitsu Key News
7.2 Mylan
7.2.1 Mylan Corporate Summary
7.2.2 Mylan Business Overview
7.2.3 Mylan Non-opioid Pain Patch Major Product Offerings
7.2.4 Mylan Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.2.5 Mylan Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Non-opioid Pain Patch Major Product Offerings
7.3.4 Johnson & Johnson Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.3.5 Johnson & Johnson Key News
7.4 Actavis
7.4.1 Actavis Corporate Summary
7.4.2 Actavis Business Overview
7.4.3 Actavis Non-opioid Pain Patch Major Product Offerings
7.4.4 Actavis Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.4.5 Actavis Key News
7.5 Lingrui
7.5.1 Lingrui Corporate Summary
7.5.2 Lingrui Business Overview
7.5.3 Lingrui Non-opioid Pain Patch Major Product Offerings
7.5.4 Lingrui Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.5.5 Lingrui Key News
7.6 Teikoku Seiyaku
7.6.1 Teikoku Seiyaku Corporate Summary
7.6.2 Teikoku Seiyaku Business Overview
7.6.3 Teikoku Seiyaku Non-opioid Pain Patch Major Product Offerings
7.6.4 Teikoku Seiyaku Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.6.5 Teikoku Seiyaku Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Non-opioid Pain Patch Major Product Offerings
7.4.4 Sanofi Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.7.5 Sanofi Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Non-opioid Pain Patch Major Product Offerings
7.8.4 Novartis Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.8.5 Novartis Key News
7.9 Qizheng
7.9.1 Qizheng Corporate Summary
7.9.2 Qizheng Business Overview
7.9.3 Qizheng Non-opioid Pain Patch Major Product Offerings
7.9.4 Qizheng Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.9.5 Qizheng Key News
7.10 Endo
7.10.1 Endo Corporate Summary
7.10.2 Endo Business Overview
7.10.3 Endo Non-opioid Pain Patch Major Product Offerings
7.10.4 Endo Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.10.5 Endo Key News
7.11 Huarun 999
7.11.1 Huarun 999 Corporate Summary
7.11.2 Huarun 999 Non-opioid Pain Patch Business Overview
7.11.3 Huarun 999 Non-opioid Pain Patch Major Product Offerings
7.11.4 Huarun 999 Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.11.5 Huarun 999 Key News
7.12 GSK
7.12.1 GSK Corporate Summary
7.12.2 GSK Non-opioid Pain Patch Business Overview
7.12.3 GSK Non-opioid Pain Patch Major Product Offerings
7.12.4 GSK Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.12.5 GSK Key News
7.13 Haw Par
7.13.1 Haw Par Corporate Summary
7.13.2 Haw Par Non-opioid Pain Patch Business Overview
7.13.3 Haw Par Non-opioid Pain Patch Major Product Offerings
7.13.4 Haw Par Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.13.5 Haw Par Key News
7.14 Nichiban
7.14.1 Nichiban Corporate Summary
7.14.2 Nichiban Business Overview
7.14.3 Nichiban Non-opioid Pain Patch Major Product Offerings
7.14.4 Nichiban Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.14.5 Nichiban Key News
7.15 Mentholatum
7.15.1 Mentholatum Corporate Summary
7.15.2 Mentholatum Business Overview
7.15.3 Mentholatum Non-opioid Pain Patch Major Product Offerings
7.15.4 Mentholatum Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.15.5 Mentholatum Key News
7.16 Laboratoires Genevrier
7.16.1 Laboratoires Genevrier Corporate Summary
7.16.2 Laboratoires Genevrier Business Overview
7.16.3 Laboratoires Genevrier Non-opioid Pain Patch Major Product Offerings
7.16.4 Laboratoires Genevrier Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.16.5 Laboratoires Genevrier Key News
7.17 BLUE-EMU
7.17.1 BLUE-EMU Corporate Summary
7.17.2 BLUE-EMU Business Overview
7.17.3 BLUE-EMU Non-opioid Pain Patch Major Product Offerings
7.17.4 BLUE-EMU Non-opioid Pain Patch Sales and Revenue in Global (2016-2021)
7.17.5 BLUE-EMU Key News
8 Global Non-opioid Pain Patch Production Capacity, Analysis
8.1 Global Non-opioid Pain Patch Production Capacity, 2016-2027
8.2 Non-opioid Pain Patch Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-opioid Pain Patch Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-opioid Pain Patch Supply Chain Analysis
10.1 Non-opioid Pain Patch Industry Value Chain
10.2 Non-opioid Pain Patch Upstream Market
10.3 Non-opioid Pain Patch Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-opioid Pain Patch Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Non-opioid Pain Patch in Global Market
Table 2. Top Non-opioid Pain Patch Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Non-opioid Pain Patch Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Non-opioid Pain Patch Revenue Share by Companies, 2016-2021
Table 5. Global Non-opioid Pain Patch Sales by Companies, (M Units), 2016-2021
Table 6. Global Non-opioid Pain Patch Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Non-opioid Pain Patch Price (2016-2021) & (USD/K Units)
Table 8. Global Manufacturers Non-opioid Pain Patch Product Type
Table 9. List of Global Tier 1 Non-opioid Pain Patch Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-opioid Pain Patch Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU